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Albendazole (ALB) is a potent benzimidazole anthelmintic used in the treatment of human intestinal helmintiasis as well as of
hytatid cysts and neurocysticercosis. Two rapid, simple, sensitive, and selective spectrophotometric methods are presented for
the determination of ALB in pharmaceuticals. The methods are based on the formation of dichloromethane soluble 1 : 1 ion-pair
complexes (ALB : dye) formed between ALB and sulfonphthalein dyes, bromophenol blue BPB, (method A) and bromothymol blue
BTB, (method B).The complexes formed were measured directly (without extraction) at 445 nm (method A) and 460 nm (method
B).The experimental conditions were optimized and the systems obey Beer’s law for 1.5–21.0 and 2.0–32.0 𝜇gmL−1 ALB formethod
A and method B respectively. The molar absorptivity and Sandell’s sensitivity were calculated to be 1.27 × 104 Lmol−1 cm−1 and
0.0209 ng cm−2, and 7.57 × 103 Lmol−1 cm−1 and 0.0350 ng cm−2 using BPB and BTB, respectively. The limits of detection and
quantificationwere calculated to be 0.01 and 0.03, and 0.16, and 0.49 𝜇gmL−1 using BPB and BTB, respectively.The relative standard
values for intra-day and inter-day precision were less than 3%, and the accuracy was better than 3% for both methods.
1. Introduction
Albendazole (ALB), chemically known as methyl-5-(propyl
thio)-2-yl benzimidazolemethyl carbamate [1], is widely used
as an anthelmintic having a wide spectrum of activity [2].The
drug is official in British Pharmacopoeia [3], which describes
a potentiometric titrationwith perchloric acid in formic acid-
acetic acid medium. Quantitative determination of ALB in
dosage forms has received wide attention and several meth-
ods have been reported and include titrimetry in nonaqueous
medium [4, 5], redox titrimetry [6–12], UV spectrophotome-
try [13–17], spectrofluorimetry [18, 19], voltammetry [20–22],
high performance liquid chromatography [23–27], and high
performance thin layer chromatography [28, 29].
Several visible spectrophotometric methods, both direct
and indirect, are found in the literature for the determination
of ALB in pharmaceuticals. Basavaiah et al. [30] in their
methods treated ALB with a known excess of NBS in HCl
medium, and the unreacted oxidant was reduced by iron(II)
and the resulting iron(III) was complexed with thiocyanate
or tiron offering two sensitive methods. Two more indirect
methods [31] involving NBS-metol-sulfanilamide and NBS-
celesteine blue as chromogenic systems have been proposed
by Sastry et al. Several other reaction schemes involving chlo-
ramine-T-methyl orange or indigocarmine [6], chloramine-
T-metol-sulfanilic acid [7], NBS-methyl orange or indigo-
carmine [10], N-chlorosuccinimide-iron(II)-thiocyanate [11],
NaIO
4
-KBr-methyl orange or indigocarmine [12], and per-
chloric acid-crystal violet [4] are also found in the literature
for the indirect spectrophotometric assay of ALB in its dosage
forms.
Only a few direct spectrophotometric methods are
reported for ALB. Zarapkar and Deshpande [32] have deter-
mined the drug in tablets and syrups based on the reduction
of Folin-Ciocalteu reagent to a blue coloured chromogen
which was measured at 700 nm.The charge-transfer reaction
2 ISRN Analytical Chemistry
of ALB with 𝜋-acceptor chloranilic acid in alcoholic acetone
medium was used by Zhao et al. [33] for the determina-
tion of the drug in tablets. Based on similar reaction and
employing chloranilic acid and 2,3-dichloro-5,6-dicyano-
p-benzoquinone (DDQ) as 𝜋-acceptors, determination of
ALB in tablets has been reported by Refat et al. [34]. Ion-
pair reaction involving ALB and acidic dyes has been the
basis of extractive spectrophotometric assay of ALB [35–
37]. Sane et al. [35] have described four procedures based
on this reaction using bromocresol green, bromophenol
blue, bromothymol blue, and bromophenol red as ion-pair
reagents in acidic buffer medium. The ion-pair complexes
formed were extracted into chloroform and measured at
420 nm. The methods were applied to tablets and syrup.
Thymol blue and six alizarin derivatives [36] are the other
ion-pair reagents used for the assay of ALB. Sastry et al. [37]
have devised extractive spectrophotometric methods for the
estimation of some benzimidazole anthelmintics including
ALB in pharmaceuticals based on ion-pair reaction and
employing some acidic dyes.
All the indirect spectrophotometric methods cited above
[4, 6, 7, 10–12, 30, 31] are cumbersome involving multi-
reagents and multistep reactions and, hence prone to inaccu-
racy and imprecision. On the other hand, the reported direct
spectrophotometric methods [33, 34] are less sensitive with
the molar absorptivity value being <1 × 104 Lmol−1 cm−1.
The methods based on ion-pair reaction [35–37], though
sensitive, involve tedious and time consuming extraction step
besides being critically dependent on pH of the aqueous
phase and the aqueous-organic phases ratio. Additionally,
incomplete extraction of the analyte may lead to erratic
results. In an attempt to overcome these shortcomings
associated with extractive spectrophotometric methods, sev-
eral workers in recent years have devised extraction-free
spectrophotometricmethods for several pharmaceutical sub-
stances [38–45] based on ion-pair reaction and employing
some sulfonphthalein dyes. These new procedures are free
from critical pH adjustment and laborious liquid-liquid
extraction step and involve simple mixing the drug and dye
solutions in organic solvent and measuring the absorbance
of the resulting ion-pair complex at wavelength of maximum
absorption.
The present work presents two simple, rapid, sensitive,
and selective spectrophotometric methods for ALB based
on ion-pair reaction and using bromophenol blue (BPB)
and bromothymol blue (BTB) as ion pair reagents. The
striking feature of these methods is the absence of the
extraction step, and the methods are absolutely free from
critical experimental variables, unlike the direct and indirect
spectrophotometricmethods cited earlier.Theywere demon-
strated to be highly precise and accurate besides being robust
and rugged.
2. Experimental
2.1. Apparatus. A Systronics model 166 digital spectropho-
tometer (Systronics, Ahmedabad, Gujarat, India) equipped
with 1 cm matched quartz cells was used for all absorbance
measurements.
2.2. Materials. Pharmaceutical grade ALB (99.7 percent
pure) was received as a gift from Cipla India, Ltd., Mum-
bai, India and used as received. Alworm-400 (Medopharm
Ltd., Malur, India), ABD-400 (Intas Pharmaceuticals, Ltd.,
Ahmedabad, India,) and Bandy-400 (Mankind Pharmaceu-
ticals, Ltd., New Delhi, India) tablets were purchased from
local commercial sources.
2.3. Reagents and Chemicals. All reagents used were of
analytical reagent grade, and HPLC grade organic solvents
were used throughout the investigation.
A 0.025% bromophenol blue (Loba Chemie Pvt. Ltd.,
Mumbai, India) and 0.1% bromothymol blue (Qualigens Fine
Chemicals, Mumbai, India) solutions were prepared sepa-
rately in dichloromethane (DCM, Merck, Mumbai, India;
specific gravity 1.32) and used in method A and method B,
respectively.
2.4. Standard ALB Solution. A stock standard solution con-
taining 100 𝜇gmL−1 ALB was prepared by dissolving 10mg
of pure drug in dichloromethane and diluting to mark with
the same solvent in a 100mL calibrated flask. This was
diluted appropriately with the same solvent to obtainworking
concentration of 30𝜇gmL−1 for method A and 40𝜇gmL−1
ALB for method B.
2.5. Assay Procedures
2.5.1. Method A (Using Bromophenol Blue, BPB). Different
aliquots of 0.25, 0.5, 1.0, 2.0, 3.0, and 3.5mL of standard ALB
solution (30 𝜇gmL−1) were accurately transferred to 5mL
standard flasks using a microburette, and the total volume
was adjusted to 3.5mL by adding adequate quantity of DCM.
One mL of 0.025% BPB was added to each flask and the
mixturewas diluted to the volumewithDCMandmixedwell.
The absorbance of each solution was measured at 445 nm
against a reagent blank after 5min.
2.5.2. Method B (Using Bromothymol Blue, BTB). Aliquots of
0.25, 0.5, 1.0, 2.0, 3.0, 3.5, and 4.0mLof standardALB solution
(40 𝜇gmL−1) were measured accurately and added to 5mL
calibrated flasks using a microburette, and the total volume
was adjusted to 4.0mL with DCM. One mL of 0.1% BTB was
added to each flask and themixture was diluted to the volume
with DCM and mixed well. After 5min, the absorbance of
each solutionwasmeasured at 460 nmagainst a reagent blank
prepared simultaneously.
A standard graph was prepared by plotting absorbance
against concentration, and the unknown concentration was
read from the graph or computed from the regression
equation derived using Beer’s law data.
2.6. Procedure for Tablets. Thecontent of ten tablets each con-
taining 400mg ALB was weighed accurately and grounded
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into a fine powder. An accuratelyweighed quantity equivalent
to 10mg of ALBwas transferred into a 100mL calibrated flask
and dissolved in 60mL of DCM. The content was shaken
thoroughly for 15–20min, diluted to the mark with DCM,
mixed well, and filtered using a Whatman no. 42 filter paper.
The first 10mL portion of the filtrate was discarded, and a
suitable aliquot of the filtrate (100𝜇gmL−1) was diluted to
obtain working concentration of 30𝜇gmL−1 in method A
and 40𝜇gmL−1 in method B with DCM and was analysed
by taking an appropriate volume in both methods.
2.7. Procedure for the Selectivity Study. Selectivity was evalu-
ated by using placebo blank and synthetic mixture analysis.
A placebo blank, consisting of starch (20mg), acacia (25mg),
hydroxyl cellulose (20mg), sodium citrate (30mg), talc
(20mg), magnesium stearate (25mg), and sodium alginate
(20mg), was prepared by thorough mixing and its solutions
described under procedure for tablets and then were sub-
jected to analysis.
A syntheticmixturewas prepared by adding 10mg of pure
ALB to ∼10mg of the above mentioned placebo blank, and
the mixture was homogenized. Following the procedure used
for tablets, the synthetic mixture solution was prepared, and
a suitable quantity was subjected to analysis by both methods
(𝑛 = 3) after appropriate dilution.
3. Results and Discussion
3.1. Absorption Spectra. Thereaction of BPBorBTBwithALB
results in the formation of intense yellow coloured product.
The absorption of coloured products was recorded at 360–
520 nm against the corresponding reagent blank solutions.
The resulting coloured ion pair complexes showedmaximum
absorbance at 445 nmand 460 nm forALB-BPB (a) andALB-
BTB (b), respectively. Thus, all absorbance measurements
were thus made at these wavelengths (Figure 1).
3.2. Reaction Pathway. ALB forms ion-pair complexes with
dyes such as BPB and BTB, since it contains a tertiary
amino group which is protonated in the solvent medium
used. Chemically, the structure of ALB features its basic
nature. This structure suggests the possibility of utilizing an
anionic dye as chromogenic reagent. In dichloromethane,
ALB does not absorb in the visible region. In contrast, when a
solution of BPB/BTB in dichloromethane is added to the drug
solution, an intense yellow coloured product is produced
immediately. This is due to an opening of lactoid ring of the
dye and subsequent formation of quinoid group [46]. It is
supposed that the two tautomers are present in equilibrium
but due to strong acidic nature of the sulfonic acid group,
the quinoid bodymust predominate. Finally, protonated ALB
forms ion-pair with the anionic dye. The possible reaction
pathway is shown in Schemes 1 and 2. Anionic dye as
BPB or BTB forms ion-pair complex with positively charged
drug. Each drug-dye ion-pair complex molecule, with two
oppositely charged ions, behaves as a single unit held together
by an electrostatic force of attraction (Schemes 1 and 2).
Table 1: Sensitivity and regression parameters.
Parameter Method A Method B
𝜆max, nm 445 460
Colour stability, min 90 60
Linear range, 𝜇gmL−1 1.5–21.0 2.0–32.0
Molar absorptivity (𝜀), Lmol−1 cm−1 1.27 × 104 7.57 × 103
Sandell sensitivity∗, 𝜇g cm−2 0.0209 0.0350
Limit of detection (LOD), 𝜇gmL−1 0.01 0.16
Limit of quantification (LOQ), 𝜇gmL−1 0.02 0.49
Regression equation, 𝑌∗∗
Intercept (𝑎) 0.0358 0.0049
Slope (𝑏) 0.042 0.028
Standard deviation of 𝑎 (𝑆
𝑎
) 9.98 × 10−2 9.98 × 10−2
Standard deviation of 𝑏 (𝑆
𝑏
) 5.53 × 10−3 3.39 × 10−3
Regression coefficient (r) 0.9975 0.9997
∗Limit of determination as the weight in 𝜇gmL−1 of solution, which
corresponds to an absorbance of 𝐴 = 0.001 measured in a cuvette of cross-
sectional area 1 cm2 and 𝑙 = 1 cm.
∗∗
𝑌 = 𝑎 + 𝑏𝑋, where 𝑌 is the absorbance,𝑋 is concentration in 𝜇gmL−1, 𝑎
is intercept, and 𝑏 is slope.
3.3. Optimisation of Reaction Conditions
3.3.1. Effect of Reagent Concentration. The effect of the
dye concentration on the intensity of the colour devel-
oped at selected wavelengths was studied by measuring the
absorbances of solutions containing a fixed concentration of
ALB and different amounts (0.5–2.5mL) of the respective
dye of 0.025% BPB and 0.1% BTB solution. Maximum colour
intensity was achieved with 1mL of dye in each case and
excess dye did not affect the absorbance of the complex
(Figure 2).
3.3.2. Effect of Solvent. In order to select the suitable solvent
for ion-pair complex formation, the reaction ofALBwithBPB
and BTB was carried out in different solvents such as DCM,
chloroform, acetonitrile, methanol, 1,2-dichloroethane, 1,4-
dioxane, and benzene. The DCM was found to be ideal
solvent for both methods A and B (Figure 3). Similarly, the
effect of the diluting solvent was studied for both methods
and the results showed that DCM was best suited for both
methods with low blank absorbance and high complex
absorbance.
3.3.3. Effect of Reaction Time and Stability of Colour. The
addition of the dye solution resulted in an immediate full
colour development at ambient temperature and the formed
ion-pair complexes were stable for at least 1.5 h in method A
and half an hour in method B. The reaction was found to be
complete quantitative when the reactionmixture was allowed
to stand for 5min.
3.3.4. Stoichiometric Relationship. Job’s method of contin-
uous variations of equimolar solutions was employed to
establish the stoichiometry of formed ion-pair complexes.
Solutions equivalent to 1.13 × 10−4M ALB and BPB were
















































Scheme 1: Reaction mechanism for the formation of ALB-BPB ion-pair complex.
Table 2: Evaluation of Intra-day and inter-day accuracy and precision.

























































aMean value of 7 determinations; brelative standard deviation (%); crelative error (%).
prepared in DCM in method A, and 3.02 × 10−4M ALB and
BTB were prepared in method B by dissolving the calculated
quantities in DCM. A series of solutions was prepared in
which the total volume of ALB and reagent was kept at
3.0mL in 5mL calibrated flask. The solutions were well
mixed; the volume was completed to the mark with DCM.
The absorbance of the resulting solution was measured after
10min at the respective wavelengths ofmaximumabsorbance
against the organic solvent as blank in the respectivemethods.
The resulting graph (Figure 4) shows that the interaction
occurs on an equimolar basis (1 : 1 reaction stoichiometry),
owing to the presence of one basic nitrogen containing group
in the ALB molecule.
The conditional stability constant (𝐾
𝑓
) of the ion-
association complex was calculated from the continuous

















are the observed maximum absorbance and
the absorbance value when all the drug present is associated,
respectively. 𝐶
𝑀
is the molar concentration of drug at the
maximum absorbance and 𝑛 is the stoichiometry with which
BPB/BTB ion associates with ALB ion. The log𝐾
𝑓
values
were found to be 7.58 and 6.62 for method A and method B,
respectively.
3.4. Method Validation
3.4.1. Linearity, Sensitivity, Limits of Detection, and Quantifi-
cation. A linear correlationwas found between absorbance at
𝜆max and concentration of ALB in the ranges given in Table 1.
The graphs are described by the regression equation:
𝑌 = 𝑎 + 𝑏𝑋, (2)
where 𝑌 = absorbance of 1 cm layer of solution, 𝑎 = intercept,
𝑏 = slope, and 𝑋 = concentration in 𝜇gmL−1. Regression
analysis of the Beer’s law data using the method of least
squares was made to evaluate the slope (𝑏), intercept (𝑎), and









































































































ALB + BTB ion-pair complex
(b)
Figure 1: Absorption spectra.
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ALB + BTB ion-pair complex
(b)
Figure 2: Effect of reagent volume of (a) 0.05% BPB and (b) 0.1% BTB dye solution on the absorbance of ion-pair complex and blank

























































































ALB + BTB ion-pair complex
(b)
Figure 3: Effect of solvent (8𝜇gmL−1 ALB in method A and 20 𝜇gmL−1 in method B).
Table 3: Method robustness and ruggedness expressed as intermediate precision.






































aIn both methods, the volumes of reagent were 1 ± 0.1mL.
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Figure 4: Job’s continuous variations plot for (a) ALB-BPB ion-pair complex𝑉ALB and𝑉BPB are volumes of ALB and BPB (both 1.13 × 10
−4M),
respectively, and (b) ALB-BTB ion-pair complex 𝑉ALB and 𝑉BPB are volumes of ALB and BTB (both 3.02 × 10
−4M), respectively.
Table 4: Results of analysis of tablets by the proposed methods.
Tablets analysed Label claim, mg/tablet
Found∗ (Percent of label claim ± SD)
Reference method Proposed methods
Method A Method B
Alworm 400 400 101.2 ± 0.75
100.5 ± 1.20 101.8 ± 1.01
𝑡 = 1.11 𝑡 = 1.07
𝐹 = 2.56 𝐹 = 1.81
ABD 400 400 99.8 ± 0.56
99.9 ± 1.19 100.8 ± 1.25
𝑡 = 0.17 𝑡 = 1.63
𝐹 = 4.52 𝐹 = 4.98
Bandy 400 400 100.8 ± 0.78
100.3 ± 1.69 100.7 ± 1.55
𝑡 = 0.6 𝑡 = 0.13
𝐹 = 4.69 𝐹 = 3.95
∗Mean value of five determinations.
Tabulated 𝑡 value at the 95% confidence level is 2.78.
Tabulated 𝐹 value at the 95% confidence level is 6.39.
correlation coefficient (𝑟) for each system and the values are
presented in Table 1.The optical characteristics such as Beer’s
law limits, molar absorptivity, and Sandell’s sensitivity values
[48] of all the three methods are also given in Table 1.
The limits of detection (LOD) and quantitation (LOQ)




, LOQ = 10𝑆
𝑏
, (3)
where 𝑆 is the standard deviation of blank absorbance values,
and 𝑏 is the slope of the calibration plot are also presented
in Table 1. The values of 𝜀 and Sandell’s sensitivity and LOD
indicate the sensitivity of the proposed methods.
3.5. Accuracy and Precision. To evaluate the accuracy and
precision of the proposed methods, pure ALB solution at
three different concentration levels (within working range)
was prepared and analyzed in seven replicates during the
same day (intraday precision) and on five consecutive days
(interday precision) and the results are presented in Table 2.
The percentage relative error (RE%)was≤2.18 which indicate
that the accuracy of the methods is satisfactory. Percentage
relative standard deviation (RSD %) for intraday was ≤2.25
and for interday was ≤2.35 indicating repeatability and
usefulness of the proposed methods in the analysis.
3.6. Selectivity. In order to evaluate the selectivity of the
proposed methods for the analysis of pharmaceutical for-
mulations, the effect of the presence of common excipients
was tested for possible interference in the assay by placebo
blank and synthetic mixture analyses. The absorbance of
the reaction product with the placebo blank was almost
equal to the absorbance of the reagent blank suggesting no
interference from the tablet excipients.Thepercent recoveries
of ALB were 98.3 ± 2.2 and 101.2 ± 2.6 for methods A and B,
respectively. This confirms the selectivity of the methods in
the presence of the common tablet excipients.
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Table 5: Results of recovery study via standard addition method with tablet.





𝜇gmL−1 Pure ALB recovered
∗ percent ± SD
A
Alworm 400
6.03 3.0 9.07 101.30 ± 1.52
6.03 6.0 12.13 101.70 ± 1.61
6.03 9.0 15.07 100.50 ± 2.11
ABD 400
5.99 3.0 8.97 99.34 ± 1.89
5.99 6.0 12.00 100.20 ± 2.34
5.99 9.0 14.96 99.74 ± 2.30
Bandy 400
6.02 3.0 9.03 100.40 ± 2.07
6.02 6.0 11.99 99.50 ± 2.59
6.02 9.0 15.01 99.96 ± 2.81
B
Alworm 400
8.14 4.0 12.16 100.60 ± 1.31
8.14 8.0 16.15 100.20 ± 2.56
8.14 12.0 20.13 99.91 ± 2.48
ABD 400
8.06 4.0 12.09 100.90 ± 1.49
8.06 8.0 16.15 101.20 ± 1.56
8.06 12.0 20.13 100.60 ± 2.48
Bandy 400
8.05 4.0 12.03 99.45 ± 1.35
8.05 8.0 16.15 101.30 ± 2.56
8.05 12.0 20.13 100.70 ± 2.48
∗Mean value of three determinations.
3.7. Robustness and Ruggedness. To determine the robustness
of the proposed methods, an important experimental vari-
able, volume of reagent was slightly varied and the effect of
this change on the absorbance of the ion-pair complex was
studied. The results of this effect are presented in Table 3
and indicated that the proposed methods are robust. Method
ruggedness was evaluated by performing the analysis follow-
ing the general procedures by three different analysts and on
three different spectrophotometers by the same analyst. From
the%RSD values presented in Table 3, it is concluded that the
proposed methods are rugged.
3.8. Application for Tablets. The proposed methods were
applied to the determination of ALB in tablets. The results
obtained were statistically compared with those of the official
method [3] by applying Student’s 𝑡-test for accuracy and 𝐹-
test for precision. The official method describes a potentio-
metric titration with perchloric acid in formic acid-acetic
acid medium. As can be seen from Table 4, the calculated
𝑡 and 𝐹 values at 95% confidence level did not exceed the
tabulated values of 2.78 and 6.39, respectively, for four degrees
of freedom. The results showed that there is no difference
between the proposed methods and the official method with
respect to accuracy and precision.
3.9. Recovery Study. To further assess the accuracy of the
methods, recovery experiments were performed by applying
the standard-addition technique. The recovery was assessed
by determining the agreement between the measured stan-
dard concentration and added known concentration to the
sample. The test was done by spiking the preanalysed tablet
powder with pure ALB at three different levels 50, 100, and
150% of the content present in the tablet powder (taken) and
the total was found by the proposed methods. Each test was
repeated three times. In all the cases, the recovery percentage
values ranged between 99.34% and 101.7% with standard
deviation in the range 1.31%–2.81%. Closeness of the results
to 100% showed the fairly good accuracy of the methods.The
results are shown in Table 5.
4. Conclusions
Two spectrophotometric methods for the determination of
albendazole in bulk drug and in tablets were developed and
validated for accuracy, precision, linearity, robustness, and
ruggedness. The methods employ more normal conditions
than those previously reported and rely onwell-characterised
ion-pair formation reactions. Besides, the methods have the
advantages of simplicity without involving heating or extrac-
tion step and high sensitivity. The proposed methods are
rapid, simple and in addition offer advantages in determining
ALB (in tablets), when extraction difficulties arise with other
spectrophotometric methods based on ion-pair extraction
(Table 6). Hence, the proposedmethods could be adopted for
quality control in pharmaceutical industries.
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Table 6: Comparison of the performance characteristics of the present methods with the published method Spectrophotometry.
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Table 6: Continued.
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∗BCG: bromo cresol green, BTB: bromo thymol blue, BPB: bromo phenol blue, BPR: bromo phenol red, p-CAA: chloranilic acid.
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